Pfizer (FRA:PFE) Short-Term Debt : €9,487 Mil (As of Dec. 2023)

View and export this data going back to 1951. Start your Free Trial

What is Pfizer Short-Term Debt?

Pfizer's Short-Term Debt for the quarter that ended in Dec. 2023 was €9,487 Mil.

Pfizer's quarterly Short-Term Debt declined from Jun. 2023 (€3,678 Mil) to Sep. 2023 (€2,387 Mil) but then increased from Sep. 2023 (€2,387 Mil) to Dec. 2023 (€9,487 Mil).

Pfizer's annual Short-Term Debt increased from Dec. 2021 (€1,983 Mil) to Dec. 2022 (€2,770 Mil) and increased from Dec. 2022 (€2,770 Mil) to Dec. 2023 (€9,487 Mil).

Pfizer Short-Term Debt Historical Data

The historical data trend for Pfizer's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Short-Term Debt Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

14,571.00

2,221.87

1,983.29

2,769.70

9,487.28

Pfizer Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Debt	Get a 7-Day Free Trial															2,769.70	3,912.53	3,678.16	2,387.48	9,487.28

Pfizer Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Pfizer Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Pfizer's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (FRA:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (FRA:PFE) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.